PURPOSE: This rule defines the terms used in this chapter.

1. (1) Client is a person who meets eligibility requirements as defined by 19 CSR 40-7.020 Program Eligibility, and is approved for participation in the phenylketonuria (PKU) program.
2. (2) Department is the Missouri Department of Health.
3. (3) Formula Distribution Program (FDP) is a program of the department through which low-protein formula, a special dietary product, is provided to individuals diagnosed as having PKU, maple syrup urine disease (MSUD) and other metabolic conditions as approved by the Newborn Screening Standing Committee. The Newborn Screening Standing Committee, a subcommittee of the Missouri Genetic Advisory Committee, makes recommendations on newborn screening issues.
4. (4) Maple syrup urine disease (MSUD) is a metabolic disorder due to a defect in the enzyme that is responsible for the metabolism of the essential branched-chain amino acids isoleucine, leucine and valine.
5. (5) Metabolic treatment center is a medical facility with the capacity to diagnosis metabolic conditions and to provide comprehensive medical management.
6. (6) Phenylketonuria (PKU) is a hereditary disorder of phenylalanine metabolism characterized by brain damage and mental retardation due to accumulation of toxic metabolic products.
7. (7) Resident is an individual being present in Missouri with the intention to abandon their previous domicile and to remain in Missouri permanently.
8. (8) This rule expires on June 30, 2002.

AUTHORITY: sections 191.300– 191.380, RSMo (1994 and Supp. 1995).* Emergency rule filed Aug. 19, 1996, effective Aug. 29, 1996, expired Feb. 24, 1997. Original rule filed Aug. 15, 1996, effective Jan. 30, 1997. *Original authority: 191.300–191.310, RSMo (1985); 191.315, RSMo (1985), amended 1993, 1995; 191.317–191.325, RSMo (1985); 191.331, RSMo (1965), amended 1985, 1992, 1993, 1995; 191.335, RSMo (1979); 191.340, RSMo (1979), amended 1985; 191.360–191.362, RSMo (1983); and 191.365–191.380, RSMo (1985).